To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SFRS18andCOQ3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
794 representative clones for gene SFRS18andCOQ3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_015491.1   .a 1 to 3141 2 to 3142 exact RefSeq,   3142/3142
(100 %)
0 diff
(100 %id)
DW412867 Liver .a 16 to 322 16 to 322   tiling clone,   307/322
(95 %)
8 diff
(97.6 %id)
DW417371 Liver .a 17 to 313 10 to 306       297/306
(97 %)
6 diff
(98.1 %id)
BP311163 brain .a 23 to 605 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA135940 alzheimer cortex .a 24 to 567 2 to 545   capped   544/545
(99 %)
1 diff
(99.9 %id)
DA281129 corpus callosum .a 24 to 587 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB115983 thymus .a 24 to 583 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DB156756 thymus .a 24 to 592 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB290759 uterus .a 24 to 617 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA124938 cerebellum .a 26 to 594 2 to 572   capped   571/573
(99 %)
5 diff
(99.2 %id)
DB291708 uterus .a 26 to 605 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA992239 synovial membrane tissue from rheumatioidarthritis .a 27 to 576 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
DW430262 Liver .a 28 to 399 18 to 389       372/389
(95 %)
7 diff
(98.3 %id)
DW457434 Liver .a 28 to 172 18 to 162       145/162
(89 %)
8 diff
(95.1 %id)
BP334946 salivary gland .a 28 to 611 1 to 581       581/581
(100 %)
7 diff
(98.8 %id)
DA126578 cerebellum .a 29 to 595 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB161266 thymus .a 29 to 620 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA493898 brain .a 31 to 510 2 to 481   capped   480/480
(100 %)
0 diff
(100 %id)
BX486572   .a 33 to 666 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
DA281013 corpus callosum .a 34 to 619 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
BU533657 mixed (pool of 40 RNAs) .a 35 to 733 1 to 710       710/845
(84 %)
25 diff
(97.1 %id)
DW463038 Liver .a 36 to 388 12 to 364       353/364
(96 %)
8 diff
(97.9 %id)
BG942190 blood .a 38 to 363 1 to 326       326/326
(100 %)
3 diff
(99.1 %id)
DA619346   .a 40 to 617 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DW420520 Liver .a 41 to 322 19 to 300       282/300
(94 %)
6 diff
(98.0 %id)
BG621277 placenta .a 41 to 644 1 to 601       601/601
(100 %)
7 diff
(98.9 %id)
BP328022 prostata .a 42 to 625 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DB162999 thymus .a 42 to 645 2 to 605   capped   604/604
(100 %)
0 diff
(100 %id)
CA849166 Pancreas, Purified pancreatic islet .a 43 to 667 1 to 625   fully sequenced,   625/625
(100 %)
0 diff
(100 %id)
BP359424 mammary gland .a 43 to 615 11 to 582       572/582
(98 %)
7 diff
(98.8 %id)
DB288658 uterus .a 43 to 598 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA082662 cerebellum .a 45 to 625 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
CN343717 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 46 to 606 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BQ102480 Islets of Langerhans, Pancreas .a 46 to 560 1 to 515   fully sequenced,   515/515
(100 %)
0 diff
(100 %id)
BQ086201 Islets of Langerhans, Pancreas .a 46 to 555 1 to 510   fully sequenced,   510/510
(100 %)
0 diff
(100 %id)
BP200770 amygdala .a 47 to 628 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DW445199 Liver .a 47 to 240 17 to 210       194/223
(86 %)
18 diff
(92.0 %id)
CD634485   .a 48 to 648 8 to 605       598/711
(84 %)
9 diff
(98.8 %id)
DA423742   .a 48 to 614 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
BP350023 brain .a 48 to 634 1 to 582       586/582
(100 %)
7 diff
(98.8 %id)
CN343736 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 53 to 795 13 to 755   tiling clone,   743/755
(98 %)
6 diff
(99.3 %id)
CN343739 embryonic stem cells, cell lines H1, H7, andH9 .a 54 to 872 1 to 819       819/819
(100 %)
3 diff
(99.7 %id)
DA807513 brain .a 54 to 594 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DN990587 brain, whole brain .a 54 to 667 1 to 614       614/614
(100 %)
5 diff
(99.2 %id)
BP356707 mammary gland .a 54 to 497 1 to 444       444/444
(100 %)
3 diff
(99.4 %id)
DB165005 thymus .a 54 to 647 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DB240358 trachea .a 54 to 637 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DB137104 thymus .a 55 to 589 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
BP355630   .a 56 to 636 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DB151743 thymus .a 57 to 634 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
CA773845 Pancreas, Purified pancreatic islet .a 60 to 679 11 to 630   fully sequenced,   620/630
(98 %)
6 diff
(99.1 %id)
BI466978 Pancreas, Purified pancreatic islet .a 69 to 627 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BQ102305 Islets of Langerhans, Pancreas .a 525 to 939 415 to 1   tiling clone, fully sequenced,   415/415
(100 %)
0 diff
(100 %id)
BQ102220 Islets of Langerhans, Pancreas .a 530 to 939 410 to 1   fully sequenced,   410/410
(100 %)
0 diff
(100 %id)
BU069126 Pancreas, Purified pancreatic islet .a 618 to 938 321 to 1   fully sequenced,   321/321
(100 %)
0 diff
(100 %id)
CA848860 Pancreas, Purified pancreatic islet .a 618 to 938 321 to 1   fully sequenced,   321/321
(100 %)
0 diff
(100 %id)
BE544208 cervical carcinoma cell line, cervix .b 1 to 650 1 to 661   tiling clone,   661/774
(85 %)
21 diff
(97.3 %id)
DA326969 hippocampus .b 315 to 786 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
DA028147   .b 318 to 528 2 to 212   capped   211/211
(100 %)
0 diff
(100 %id)
NM_032870.2   .b 328 to 3549 1 to 3222 exact RefSeq,   3222/3222
(100 %)
0 diff
(100 %id)
DA208838 brain .b 329 to 899 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BP194192 brain .b 332 to 908 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BP226607   .b 337 to 918 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA533222 brain .b 340 to 902 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BP198402 adrenal gland .b 351 to 932 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP236498 coronary artery .b 351 to 933 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CB961463 placenta, pre-eclamptic placenta .b 351 to 1047 28 to 732       705/803
(87 %)
15 diff
(98.2 %id)
BP326621 prostata .b 351 to 910 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BM829107 Ascites, stomach .b 351 to 601 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BP342210 stomach mucosa .b 351 to 931 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA015547 adrenal gland .b 352 to 922 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA059074 cerebellum .b 352 to 906 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA112425 cerebellum .b 352 to 916 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA204516 brain .b 352 to 932 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA489305 brain .b 352 to 867 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DA538810 Kidney .b 352 to 939 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA690595   .b 352 to 918 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA699406   .b 352 to 882 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA933777 Spleen .b 352 to 921 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB025475 testis .b 352 to 910 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB116798 thymus .b 352 to 905 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB159379 thymus .b 352 to 911 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB276679 uterus .b 352 to 885 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BI459451 testis .b 353 to 1205 1 to 857       857/939
(91 %)
43 diff
(95.5 %id)
DA326753 hippocampus .b 357 to 1021 2 to 666   capped   665/665
(100 %)
0 diff
(100 %id)
DA927113 small intestine .b 357 to 935 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB192238 ovary, tumor tissue .b 357 to 901 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
AK027898   .b 358 to 2052 1 to 1695   available from FLJ,   1695/1695
(100 %)
2 diff
(99.9 %id)
CN343713 embryonic stem cells, DMSO-treated H9 cellline .b 359 to 1022 1 to 664       664/664
(100 %)
5 diff
(99.3 %id)
BP283587 bone marrow .b 361 to 942 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA409627 thalamus .b 362 to 906 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA933834 Spleen .b 362 to 918 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB291015 uterus .b 362 to 927 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
CA942992 Pancreas, Purified pancreatic islet .b 364 to 942 1 to 579   fully sequenced,   579/579
(100 %)
1 diff
(99.9 %id)
BY795316 eye .b 367 to 956 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BG028459 Bone, osteosarcoma, cell line .b 367 to 1055 1 to 689       689/1140
(60 %)
15 diff
(98.7 %id)
CR975539 T-Lymphocytes .b 367 to 1043 1 to 678       678/689
(98 %)
1 diff
(99.9 %id)
DA684407   .b 368 to 910 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA859940 placenta .b 371 to 920 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CN343722 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 372 to 1102 1 to 731       731/731
(100 %)
0 diff
(100 %id)
CN343723 embryonic stem cells, DMSO-treated H9 cellline .b 372 to 1107 1 to 736       736/736
(100 %)
5 diff
(99.4 %id)
DB292526 uterus .b 372 to 867 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
DA184347 amygdala .b 374 to 827 2 to 455   capped   454/454
(100 %)
0 diff
(100 %id)
AK027759 placenta .b 375 to 1347 1 to 973   available from FLJ,   973/973
(100 %)
2 diff
(99.8 %id)
BP236382 coronary artery .b 375 to 962 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BG104213 melanotic melanoma, skin .b 375 to 1104 1 to 727       727/863
(84 %)
7 diff
(99.2 %id)
CN343714 embryonic stem cells, cell lines H1, H7, andH9 .b 376 to 1152 1 to 777       777/777
(100 %)
1 diff
(99.9 %id)
CN343729 embryonic stem cells, DMSO-treated H9 cellline .b 376 to 1071 7 to 702       696/702
(99 %)
6 diff
(99.2 %id)
DA429062 colon .b 376 to 947 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AF314186 muscle .b 376 to 2055 1 to 1680       1680/1680
(100 %)
0 diff
(100 %id)
BC052638 Skin, melanotic melanoma. .b 376 to 1299 1 to 924   available from MGC, AAA   924/924
(100 %)
0 diff
(100 %id)
CB134595 Liver .b 376 to 952 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DA828288 placenta .b 376 to 981 2 to 611   fully sequenced, capped   610/610
(100 %)
3 diff
(99.6 %id)
DB132752 thymus .b 376 to 923 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB146502 thymus .b 376 to 942 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB265260 uterus .b 376 to 963 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
CN343727 embryonic stem cells, DMSO-treated H9 cellline .b 378 to 1081 1 to 704       704/715
(98 %)
1 diff
(99.9 %id)
DA756049   .b 378 to 943 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
CN343711 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 379 to 1104 1 to 728       728/728
(100 %)
7 diff
(99.1 %id)
BU156231 melanotic melanoma, skin .b 379 to 1206 1 to 837   available from MGC,   837/903
(92 %)
18 diff
(98.1 %id)
BG286631 bladder, transitional cell papilloma, cell line .b 381 to 1057 1 to 679       679/1138
(59 %)
5 diff
(99.6 %id)
BP365804 lung .b 381 to 962 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA370071 subthalamic nucleus .b 382 to 931 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB138431 thymus .b 382 to 950 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA132132 alzheimer cortex .b 384 to 951 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA409065 thalamus .b 385 to 942 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA678276   .b 385 to 1098 2 to 714   capped   713/713
(100 %)
1 diff
(99.9 %id)
DA762130 tongue .b 385 to 939 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA767891 brain .b 385 to 1169 2 to 798   capped   797/851
(93 %)
15 diff
(98.3 %id)
DB150229 thymus .b 385 to 970 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB279329 uterus .b 385 to 944 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CN343721 embryonic stem cells, DMSO-treated H9 cellline .b 386 to 906 1 to 521       521/521
(100 %)
0 diff
(100 %id)
AA333275 Embryo, 8 weeks .b 388 to 637 1 to 250       250/250
(100 %)
0 diff
(100 %id)
BM548909 duodenal adenocarcinoma, cell line, small intestine .b 389 to 1365 1 to 982       982/1036
(94 %)
27 diff
(97.4 %id)
CN343740 embryonic stem cells, DMSO-treated H9 cellline .b 394 to 1104 1 to 712       712/712
(100 %)
2 diff
(99.8 %id)
BE731820 choriocarcinoma, placenta .b 396 to 1107 1 to 709       709/955
(74 %)
8 diff
(99.2 %id)
CA941066 Pancreas, Purified pancreatic islet .b 397 to 955 1 to 559   fully sequenced,   559/559
(100 %)
2 diff
(99.7 %id)
BQ631942 Pancreas, Purified pancreatic islet .b 398 to 967 1 to 570   fully sequenced,   570/570
(100 %)
0 diff
(100 %id)
BC064640 Uterus, leiomyosarcoma .b 401 to 1347 1 to 947   available from MGC, AAA   947/947
(100 %)
0 diff
(100 %id)
BQ050521 leiomyosarcoma, uterus .b 403 to 1228 1 to 828   available from MGC,   828/995
(83 %)
11 diff
(98.9 %id)
BI193815 epithelioid carcinoma cell line, Pancreas .b 404 to 1301 1 to 901   available from MGC,   901/956
(94 %)
24 diff
(97.5 %id)
BC019074 Pancreas, epithelioid carcinoma .b 405 to 1347 1 to 943   available from MGC, AAA   943/943
(100 %)
0 diff
(100 %id)
BM694046 eye, Retina Foveal and Macular .b 406 to 764 1 to 359       359/359
(100 %)
1 diff
(99.8 %id)
CN343712 embryonic stem cells, DMSO-treated H9 cellline .b 426 to 828 1 to 403       403/403
(100 %)
0 diff
(100 %id)
CN343707 embryonic stem cells, DMSO-treated H9 cellline .b 428 to 1026 1 to 599       599/599
(100 %)
0 diff
(100 %id)
BF965942 Bone, osteosarcoma, cell line .b 475 to 1228 1 to 755       755/855
(88 %)
16 diff
(98.2 %id)
DA630982 Kidney .b 521 to 1097 2 to 579   capped   578/578
(100 %)
4 diff
(99.4 %id)
AF314184 Kidney .b 525 to 3186 1 to 2663 S518P V784A tiling clone,   2663/2663
(100 %)
3 diff
(99.9 %id)
TI_149287008   .b 539 to 1347 883 to 81   AAA   803/1081
(74 %)
16 diff
(98.6 %id)
EB387706 eye, optic nerve .b 540 to 1365 1 to 826       826/826
(100 %)
6 diff
(99.3 %id)
FN095983 breast carcinoma .b 542 to 633 91 to 1     Submitted on the opposite strand 91/93
(97 %)
3 diff
(96.8 %id)
DA738644   .b 546 to 1099 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BP383608   .b 553 to 1051 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
CN343724 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 561 to 1212 1 to 654       654/654
(100 %)
3 diff
(99.6 %id)
BP245235 Kidney .b 574 to 1155 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG116321 duodenal adenocarcinoma, cell line, small intestine .b 600 to 1094 20 to 515       496/515
(96 %)
7 diff
(98.7 %id)
DA554695   .b 609 to 1119 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
CD634486   .b 619 to 1221 615 to 11       605/615
(98 %)
1 diff
(99.9 %id)
DR159109 human embryonic stem cells differentiated toan early endodermal cell type .b 619 to 1378 1 to 760       760/760
(100 %)
0 diff
(100 %id)
CN343718 embryonic stem cells, DMSO-treated H9 cellline .b 654 to 1167 1 to 514       514/514
(100 %)
0 diff
(100 %id)
AA593229 Prostate, prostatic intraepithelial neoplasia - highgrade .b 661 to 963 304 to 1       304/304
(100 %)
3 diff
(99.1 %id)
CK023703 brain/CNS, Human Brain - Cerebellar Cortex .b 661 to 1294 1 to 631       631/702
(89 %)
14 diff
(98.1 %id)
BE810511 leiomios .b 671 to 1056 414 to 30       385/414
(92 %)
4 diff
(99.1 %id)
BE067763 breast .b 683 to 1113 1 to 431       431/436
(98 %)
14 diff
(96.8 %id)
BE067606 breast .b 684 to 1113 1 to 429       429/434
(98 %)
4 diff
(99.1 %id)
BE067772 breast .b 685 to 1114 1 to 429       429/432
(99 %)
13 diff
(97.0 %id)
BE926437 breast .b 686 to 1113 1 to 429       429/431
(99 %)
11 diff
(97.5 %id)
BF082497 breast .b 689 to 1113 3 to 424       422/429
(98 %)
10 diff
(97.7 %id)
BE067621 breast .b 691 to 1109 1 to 418       418/418
(100 %)
4 diff
(99.1 %id)
BF082503 breast .b 707 to 1113 1 to 403       403/408
(98 %)
11 diff
(97.4 %id)
BE067611 breast .b 715 to 1113 1 to 397       397/402
(98 %)
6 diff
(98.6 %id)
TI_149273070   .b 721 to 1347 714 to 88   AAA   627/844
(74 %)
5 diff
(99.5 %id)
BU675529 lung, Primary Lung Epithelial Cells .b 721 to 1347 645 to 19   AAA   627/628
(99 %)
5 diff
(99.3 %id)
CN343709 embryonic stem cells, cell lines H1, H7, andH9 .b 722 to 827 1 to 106       106/106
(100 %)
0 diff
(100 %id)
AA443017.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 722 to 1073 1 to 352     also hits gene WWC3 352/355
(99 %)
1 diff
(99.8 %id)
BM972398 lung .b 740 to 1347 626 to 19   AAA   608/608
(100 %)
0 diff
(100 %id)
AI669685 Prostate .b 780 to 1276 498 to 1       498/498
(100 %)
5 diff
(99.0 %id)
BF744026 breast .b 782 to 1113 14 to 345       332/359
(92 %)
3 diff
(99.2 %id)
FN101565 breast carcinoma .b 796 to 896 1 to 97       97/97
(100 %)
3 diff
(97.0 %id)
CB149285 Liver .b 796 to 1354 1 to 559       559/559
(100 %)
5 diff
(99.2 %id)
CR981677 T-Lymphocytes .b 829 to 1732 1 to 904       904/904
(100 %)
1 diff
(99.9 %id)
BM665799 eye, Retina Foveal and Macular .b 841 to 1347 525 to 19   AAA   507/507
(100 %)
0 diff
(100 %id)
BF591408 colon, colon tumor, RER+ .b 852 to 1346 496 to 1       496/496
(100 %)
8 diff
(98.4 %id)
CA952569 Pancreas, Purified pancreatic islet .b 852 to 1333 511 to 22       490/511
(95 %)
2 diff
(99.7 %id)
TI_151738714   .b 852 to 1347 592 to 96   AAA   497/505
(98 %)
3 diff
(99.5 %id)
DB361522.
matches multiple genes
mammary gland .b 854 to 1347 496 to 1     also hits gene siniyu 496/503
(98 %)
5 diff
(99.1 %id)
AI659846 Prostate .b 860 to 1347 488 to 1       488/488
(100 %)
0 diff
(100 %id)
AI692629 carcinoid, lung .b 860 to 1341 484 to 3       482/484
(99 %)
0 diff
(100 %id)
BE673595 Prostate .b 867 to 1347 481 to 1       481/481
(100 %)
0 diff
(100 %id)
TI_149283542   .b 870 to 1295 430 to 4       427/698
(61 %)
1 diff
(99.9 %id)
BE810508 leiomios .b 872 to 1113 7 to 249       243/254
(95 %)
3 diff
(98.9 %id)
AA847854 germinal center B cell .b 878 to 1353 479 to 4       476/479
(99 %)
0 diff
(100 %id)
BM271750 Pancreas, Purified pancreatic islet .b 881 to 1346 466 to 1       466/466
(100 %)
0 diff
(100 %id)
BF110106 carcinoid, lung .b 881 to 1334 1 to 454     Submitted on the opposite strand 454/454
(100 %)
4 diff
(99.2 %id)
BF224137 carcinoid, lung .b 881 to 1334 1 to 454     Submitted on the opposite strand 454/454
(100 %)
4 diff
(99.2 %id)
AW419370 carcinoid, lung .b 887 to 1335 1 to 449     Submitted on the opposite strand 449/449
(100 %)
3 diff
(99.4 %id)
BM353200 Pancreas, Purified pancreatic islet .b 895 to 1342 451 to 4       448/451
(99 %)
0 diff
(100 %id)
AA489707 germinal center B cell .b 899 to 1347 459 to 11   AAA   449/449
(100 %)
0 diff
(100 %id)
AA484866 Ewing's sarcoma .b 899 to 1347 469 to 21   AAA   449/449
(100 %)
0 diff
(100 %id)
AI631851 Kidney .b 902 to 1347 446 to 1       446/451
(98 %)
0 diff
(100 %id)
AI887318 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 902 to 1347 446 to 1       446/451
(98 %)
0 diff
(100 %id)
FN046315 breast carcinoma .b 906 to 965 60 to 1     Submitted on the opposite strand 60/60
(100 %)
0 diff
(100 %id)
CA942754 Pancreas, Purified pancreatic islet .b 912 to 1346 435 to 1   fully sequenced,   435/435
(100 %)
0 diff
(100 %id)
AI458699 carcinoid, lung .b 917 to 1335 1 to 420     Submitted on the opposite strand 420/420
(100 %)
2 diff
(99.6 %id)
AI681305 carcinoid, lung .b 917 to 1335 1 to 419     Submitted on the opposite strand 419/419
(100 %)
0 diff
(100 %id)
BE467003 carcinoid, lung .b 917 to 1335 1 to 419     Submitted on the opposite strand 419/419
(100 %)
0 diff
(100 %id)
AI796941 carcinoid, lung .b 918 to 1335 1 to 418     Submitted on the opposite strand 418/418
(100 %)
3 diff
(99.3 %id)
BI439764 Pancreas, Purified pancreatic islet .b 921 to 1347 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
CA866092 Pancreas, Purified pancreatic islet .b 925 to 1346 422 to 1   fully sequenced,   422/422
(100 %)
0 diff
(100 %id)
FN149810 breast carcinoma .b 928 to 1003 1 to 76       76/77
(98 %)
1 diff
(98.8 %id)
BI439763 Pancreas, Purified pancreatic islet .b 932 to 1347 416 to 1       416/416
(100 %)
0 diff
(100 %id)
BQ632236 Pancreas, Purified pancreatic islet .b 937 to 1347 411 to 1   fully sequenced,   411/411
(100 %)
0 diff
(100 %id)
CN343738 embryonic stem cells, DMSO-treated H9 cellline .b 942 to 1171 1 to 230       230/230
(100 %)
0 diff
(100 %id)
DB372759 placenta .b 951 to 1347 398 to 1   fully sequenced,   398/398
(100 %)
0 diff
(100 %id)
AA810793 germinal center B cell .b 954 to 1353 402 to 4       399/402
(99 %)
1 diff
(99.8 %id)
BJ997064 hepatoblastoma .b 960 to 1309 350 to 1       350/350
(100 %)
0 diff
(100 %id)
AW073202 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .b 966 to 1347 381 to 1       381/381
(100 %)
10 diff
(97.4 %id)
AU185112 skin .b 969 to 1151 1 to 183       183/183
(100 %)
3 diff
(98.4 %id)
CN343708 embryonic stem cells, DMSO-treated H9 cellline .b 976 to 1142 1 to 167       167/167
(100 %)
1 diff
(99.5 %id)
BX460875 brain, fetal brain .b 984 to 1999 1 to 1011       1011/1013
(99 %)
16 diff
(98.5 %id)
AW452247   .b 984 to 1347 381 to 18   AAA   364/441
(82 %)
0 diff
(100 %id)
BG547611 lung .b 990 to 1704 1 to 718       718/718
(100 %)
10 diff
(98.7 %id)
AI932728 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1023 to 1347 325 to 1       325/325
(100 %)
2 diff
(99.4 %id)
BQ378446 uterus_tumor .b 1037 to 1347 369 to 58       312/370
(84 %)
5 diff
(98.7 %id)
AI269473 pooled .b 1044 to 1336 1 to 293     Submitted on the opposite strand 293/293
(100 %)
0 diff
(100 %id)
AI565874 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1055 to 1347 294 to 1       294/294
(100 %)
8 diff
(97.3 %id)
AI620907 Prostate .b 1056 to 1347 292 to 1       292/292
(100 %)
0 diff
(100 %id)
BE504076 carcinoid, lung .b 1080 to 1301 223 to 2       222/223
(99 %)
0 diff
(100 %id)
AI566381 adenocarcinoma, Pancreas .b 1142 to 1347 206 to 1       206/206
(100 %)
0 diff
(100 %id)
BQ478418 insulinoma, Pancreas .b 1160 to 1259 1 to 100   fully sequenced,   100/100
(100 %)
0 diff
(100 %id)
FN095221 breast carcinoma .b 1171 to 1266 97 to 1     Submitted on the opposite strand 97/97
(100 %)
5 diff
(94.9 %id)
BQ478174 insulinoma, Pancreas .b 1198 to 1347 165 to 16   fully sequenced, AAA   150/150
(100 %)
0 diff
(100 %id)
FN121927 breast carcinoma .b 1227 to 1344 1 to 114       114/114
(100 %)
5 diff
(95.7 %id)
AI289175 2 pooled tumors (clear cell type), Kidney .b 1259 to 1346 88 to 1       88/88
(100 %)
2 diff
(97.8 %id)
AF161424 blood .b 1267 to 2052 1 to 786       786/786
(100 %)
0 diff
(100 %id)
AA635011 lung, lung carcinoma .b 1335 to 1542 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BQ640130 eye, retina .b 1347 to 1961 1 to 615       615/615
(100 %)
0 diff
(100 %id)
DB574760 hypothalamus .b 1575 to 2039 1 to 465     Submitted on the opposite strand 465/465
(100 %)
0 diff
(100 %id)
AI926646 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1597 to 2059 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AW518942 adenocarcinoma, Pancreas .b 1597 to 2055 459 to 1       459/459
(100 %)
0 diff
(100 %id)
FN054281 breast carcinoma .b 1660 to 1748 1 to 89       89/89
(100 %)
0 diff
(100 %id)
CR623227 Placenta Cot 25-normalized .b 1728 to 3437 1 to 1710   tiling clone,   1710/1710
(100 %)
0 diff
(100 %id)
FN176524 breast carcinoma .b 1738 to 1827 90 to 1     Submitted on the opposite strand 90/90
(100 %)
0 diff
(100 %id)
BM505201 Pancreas, Purified pancreatic islet .b 2021 to 2587 567 to 1       567/567
(100 %)
0 diff
(100 %id)
CD515614 White Matter .b 2029 to 2891 1 to 868       868/886
(97 %)
11 diff
(98.8 %id)
AA334274   .b 2031 to 2365 1 to 335       335/335
(100 %)
0 diff
(100 %id)
CR976459 T-Lymphocytes .b 2038 to 2831 1 to 798       798/798
(100 %)
5 diff
(99.4 %id)
BG697388 skin .b 2041 to 2782 1 to 742       742/742
(100 %)
1 diff
(99.9 %id)
BQ439976 melanotic melanoma, skin .b 2041 to 2879 1 to 843       843/848
(99 %)
7 diff
(99.2 %id)
FN072929 breast carcinoma .b 2061 to 2131 1 to 71       71/71
(100 %)
0 diff
(100 %id)
BM766097 stomach .b 2062 to 2514 1 to 453       453/453
(100 %)
0 diff
(100 %id)
CR998642 T-Lymphocytes .b 2071 to 2843 1 to 776       776/776
(100 %)
5 diff
(99.4 %id)
AL080186 brain .b 2073 to 4850 1 to 2776   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 2776/2776
(100 %)
7 diff
(99.8 %id)
BG697521 skin .b 2085 to 2780 1 to 697       697/699
(99 %)
3 diff
(99.6 %id)
T41107 ovary .b 2086 to 2332 247 to 1       247/247
(100 %)
0 diff
(100 %id)
FN063478 breast carcinoma .b 2096 to 2196 101 to 1     Submitted on the opposite strand 101/101
(100 %)
0 diff
(100 %id)
BP425185 small intestine .b 2121 to 2629 1 to 509     Submitted on the opposite strand 509/509
(100 %)
0 diff
(100 %id)
AF314185 Kidney .b 2122 to 3546 1 to 1425   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1425/1425
(100 %)
1 diff
(100.0 %id)
CK430786 eye, lacrimal gland .b 2164 to 2817 1 to 654       654/654
(100 %)
0 diff
(100 %id)
CB215734 normal endometrium, late proliferativephase, cycle day 13, uterus .b 2173 to 2765 1 to 593       593/593
(100 %)
0 diff
(100 %id)
AI280642 ovary, tumor, 5 pooled (see description) .b 2250 to 2627 378 to 1       378/378
(100 %)
0 diff
(100 %id)
BM311267 Pancreas, Purified pancreatic islet .b 2251 to 2637 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AW244103 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .b 2258 to 2638 381 to 1       381/381
(100 %)
0 diff
(100 %id)
AA857504 adenocarcinoma, colon .b 2277 to 2584 308 to 1       308/308
(100 %)
0 diff
(100 %id)
FN123623 breast carcinoma .b 2288 to 2374 87 to 1     Submitted on the opposite strand 87/87
(100 %)
0 diff
(100 %id)
FN174386 breast carcinoma .b 2294 to 2404 111 to 1     Submitted on the opposite strand 111/111
(100 %)
0 diff
(100 %id)
AA876271 pooled germ cell tumors .b 2318 to 2638 321 to 1       321/321
(100 %)
0 diff
(100 %id)
CR982530 T-Lymphocytes .b 2332 to 3234 1 to 901       901/901
(100 %)
9 diff
(99.1 %id)
AI921602 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2369 to 2629 261 to 1       261/265
(98 %)
0 diff
(100 %id)
FN101592 breast carcinoma .b 2426 to 2523 98 to 1     Submitted on the opposite strand 98/98
(100 %)
0 diff
(100 %id)
FN162873 breast carcinoma .b 2438 to 2542 105 to 1     Submitted on the opposite strand 105/105
(100 %)
0 diff
(100 %id)
BX348822 Placenta Cot 25-normalized .b 2459 to 3377 1 to 933       933/1000
(93 %)
38 diff
(96.2 %id)
FN064809 breast carcinoma .b 2463 to 2572 1 to 110       110/110
(100 %)
0 diff
(100 %id)
AF161379 blood .b 2534 to 3545 1 to 1006   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1006/1006
(100 %)
18 diff
(98.3 %id)
CB162184 Liver .b 2538 to 3141 1 to 604       604/604
(100 %)
0 diff
(100 %id)
AA159719   .b 2561 to 2847 1 to 291   fully sequenced, Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 291/291
(100 %)
2 diff
(99.4 %id)
BE172826 head_neck .b 2567 to 2758 192 to 1     Submitted on the opposite strand 192/192
(100 %)
0 diff
(100 %id)
BG678020 skin, squamous cell carcinoma .b 2614 to 3367 1 to 753       753/753
(100 %)
5 diff
(99.4 %id)
R83614 breast .b 2616 to 2993 1 to 379       379/379
(100 %)
1 diff
(99.8 %id)
N41611 placenta .b 2698 to 3153 1 to 464   fully sequenced,   464/464
(100 %)
9 diff
(98.1 %id)
CN343719 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2776 to 3288 1 to 513       513/513
(100 %)
0 diff
(100 %id)
TI_149274781   .b 2802 to 3546 842 to 97   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 746/997
(74 %)
19 diff
(98.1 %id)
AA159606   .b 2817 to 3081 287 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 270/270
(100 %)
0 diff
(100 %id)
W92594 heart .b 2833 to 3225 1 to 397   fully sequenced,   397/397
(100 %)
6 diff
(98.5 %id)
AA406498 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2929 to 3308 1 to 379   fully sequenced, Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
AA406520 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2929 to 3252 1 to 324   fully sequenced, Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 324/324
(100 %)
0 diff
(100 %id)
AA670150 lung, lung carcinoma .b 3108 to 3545 438 to 1       438/438
(100 %)
0 diff
(100 %id)
N29611 placenta .b 3123 to 3553 431 to 1   fully sequenced,   431/431
(100 %)
0 diff
(100 %id)
W94539 heart .b 3195 to 3546 354 to 1   fully sequenced,   354/354
(100 %)
1 diff
(99.8 %id)
AA406343 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3222 to 3546 336 to 11   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 326/326
(100 %)
1 diff
(99.7 %id)
AA406385 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3278 to 3546 280 to 11   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 270/270
(100 %)
1 diff
(99.7 %id)
R83761 breast .b 3279 to 3546 268 to 1       268/268
(100 %)
0 diff
(100 %id)
CK430624 eye, lacrimal gland .b 3289 to 3546 1 to 258   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 258/258
(100 %)
0 diff
(100 %id)
BM728513 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3328 to 4070 1 to 745       745/745
(100 %)
2 diff
(99.8 %id)
BM990074 lung, Lung Focal Fibrosis .b 3342 to 4005 1 to 667     Submitted on the opposite strand 667/667
(100 %)
3 diff
(99.6 %id)
BG956533 colon .b 3449 to 4178 730 to 1       730/730
(100 %)
1 diff
(99.9 %id)
EH346551   .b 3460 to 3525 1 to 66       66/66
(100 %)
0 diff
(100 %id)
DA568349 whole embryo, mainly head .b 3675 to 4451 2 to 783   capped   782/799
(97 %)
10 diff
(98.8 %id)
BM966942 Islets of Langerhans, Pancreas .b 3743 to 4316 1 to 574     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 574/574
(100 %)
1 diff
(99.9 %id)
BC029974 Brain, anaplastic oligodendroglioma with1p/19q loss .b 3790 to 4855 1 to 1066   tiling clone, available from MGC, AAA   1066/1086
(98 %)
2 diff
(99.9 %id)
BG819558 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3791 to 4509 1 to 730       730/929
(78 %)
19 diff
(98.0 %id)
FN134515 breast carcinoma .b 3807 to 3910 1 to 104       104/104
(100 %)
0 diff
(100 %id)
BX098346 multiple sclerosis lesions .b 3811 to 4474 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
N45016 multiple sclerosis lesions .b 3811 to 4127 1 to 318       318/318
(100 %)
2 diff
(99.4 %id)
N46701 multiple sclerosis lesions .b 3912 to 4044 1 to 133       133/133
(100 %)
0 diff
(100 %id)
FN066638 breast carcinoma .b 3925 to 3988 64 to 1     Submitted on the opposite strand 64/64
(100 %)
0 diff
(100 %id)
BG622593 placenta .b 3934 to 4661 3 to 737       735/859
(85 %)
19 diff
(97.8 %id)
AA328912   .b 3964 to 4101 1 to 138       138/138
(100 %)
0 diff
(100 %id)
BE674584 carcinoid, lung .b 4085 to 4571 487 to 1       487/487
(100 %)
0 diff
(100 %id)
BF515967   .b 4237 to 4858 639 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 622/622
(100 %)
0 diff
(100 %id)
N39256 multiple sclerosis lesions .b 4396 to 4850 458 to 1       458/459
(99 %)
3 diff
(99.4 %id)
N41004 multiple sclerosis lesions .b 4412 to 4850 442 to 1       442/446
(99 %)
4 diff
(99.2 %id)
DB354848 whole embryo, mainly head .b 4880 to 5463 575 to 1   tiling clone,   575/576
(99 %)
19 diff
(96.8 %id)
BM893682 Islets of Langerhans, Pancreas .b 4936 to 5462 543 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 528/528
(100 %)
3 diff
(99.5 %id)
C01836   .b 5247 to 5463 1 to 217       217/217
(100 %)
0 diff
(100 %id)
DB134136 thymus .c 1 to 540 2 to 541   tiling clone, capped   540/540
(100 %)
0 diff
(100 %id)
BF790807 muscle (skeletal) .c 12 to 561 1 to 546   AAA   546/811
(67 %)
10 diff
(98.8 %id)
BP214504 corpus callosum .c 13 to 599 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DW410367 Liver .c 13 to 329 18 to 334       317/334
(94 %)
8 diff
(97.7 %id)
DA211804 brain .c 14 to 580 2 to 568   capped   567/568
(99 %)
1 diff
(99.9 %id)
DB050462 testis .c 14 to 587 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB130987 thymus .c 14 to 575 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB158147 thymus .c 14 to 597 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
CN343726 embryonic stem cells, DMSO-treated H9 cellline .c 16 to 508 1 to 493       493/493
(100 %)
0 diff
(100 %id)
BM794876 Ascites, stomach .c 29 to 569 1 to 542       542/542
(100 %)
11 diff
(98.0 %id)
DA435060 tongue, tumor tissue .c 30 to 548 2 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
DA587068 lung .c 30 to 588 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB157597 thymus .c 31 to 622 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BP202920 coronary artery .c 37 to 490 1 to 454       454/582
(78 %)
8 diff
(98.7 %id)
DA160021 amygdala .c 38 to 525 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
CD674790 eye, lens .c 38 to 678 1 to 641       641/641
(100 %)
0 diff
(100 %id)
BC064413 Blood, adult leukocytes .c 38 to 1697 1 to 1661 E267R A270G T271H E272R D273R ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1661/1661
(100 %)
1 diff
(100.0 %id)
BM562137 leukocyte .c 38 to 898 1 to 860   available from MGC,   860/1079
(79 %)
16 diff
(98.6 %id)
BC007791 Placenta, choriocarcinoma .c 39 to 967 1 to 929   available from MGC, AAA   929/929
(100 %)
0 diff
(100 %id)
CN343731 embryonic stem cells, cell lines H1, H7, andH9 .c 41 to 705 13 to 677       665/677
(98 %)
6 diff
(99.2 %id)
CV571822 cornea, eye .c 41 to 623 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CN343720 embryonic stem cells, DMSO-treated H9 cellline .c 43 to 803 9 to 770       762/770
(98 %)
7 diff
(99.1 %id)
DA066339 cerebellum .c 44 to 610 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AA226975 brain, neuroepithelial cells .c 46 to 349 1 to 302       302/302
(100 %)
9 diff
(97.1 %id)
DA695965   .c 47 to 617 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB157522 thymus .c 47 to 646 2 to 601   capped   600/601
(99 %)
2 diff
(99.7 %id)
DB207577 trachea .c 48 to 588 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BM272071 Pancreas, Purified pancreatic islet .c 50 to 583 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BF695385 muscle (skeletal) .c 52 to 671 41 to 650       610/898
(67 %)
20 diff
(97.8 %id)
BE408967 choriocarcinoma, placenta .c 58 to 765 1 to 706   available from MGC,   706/724
(97 %)
11 diff
(98.5 %id)
CN343735 embryonic stem cells, DMSO-treated H9 cellline .c 61 to 690 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
CN343710 embryonic stem cells, DMSO-treated H9 cellline .c 86 to 456 1 to 371       371/371
(100 %)
0 diff
(100 %id)
BE729452 melanotic melanoma, skin .c 95 to 825 1 to 728       728/728
(100 %)
11 diff
(98.5 %id)
BE385198 melanotic melanoma, skin .c 96 to 705 1 to 610       610/617
(98 %)
3 diff
(99.6 %id)
BE743448 adenocarcinoma cell line, ovary .c 96 to 884 1 to 780       780/969
(80 %)
19 diff
(98.1 %id)
BG109598 Bone, osteosarcoma, cell line .c 135 to 886 1 to 750       750/833
(90 %)
8 diff
(99.1 %id)
BM454556 embryonal carcinoma, cell line, testis .d 1 to 739 32 to 775   tiling clone,   744/1125
(66 %)
14 diff
(98.8 %id)
DA568256 whole embryo, mainly head .d 228 to 876 2 to 651   tiling clone, capped   650/650
(100 %)
3 diff
(99.6 %id)
CN263141 embryonic stem cells, DMSO-treated H9 cellline .d 325 to 938 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
CD657055 Embryonic Stem cells .d 378 to 1180 1 to 795       795/799
(99 %)
15 diff
(98.2 %id)
AL700640 human skeletal muscle .d 510 to 992 1 to 483       483/483
(100 %)
3 diff
(99.4 %id)
FN173824 breast carcinoma .d 809 to 911 1 to 100       100/100
(100 %)
3 diff
(97.0 %id)
DA568745 whole embryo, mainly head .d 826 to 1653 2 to 836   tiling clone, capped   835/840
(99 %)
19 diff
(97.8 %id)
FN084879 breast carcinoma .d 923 to 1019 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
BM838104 Ascites, stomach .d 930 to 1588 1 to 659   tiling clone,   659/659
(100 %)
1 diff
(99.9 %id)
BF530382 anaplastic oligodendroglioma with 1p/19qloss, brain .d 964 to 1739 1 to 766       766/932
(82 %)
26 diff
(97.3 %id)
CN286092 embryonic stem cells, cell lines H1, H7, andH9 .d 1077 to 1698 624 to 3     Submitted on the opposite strand 622/624
(99 %)
0 diff
(100 %id)
CN292008 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1081 to 1785 1 to 705       705/705
(100 %)
7 diff
(99.1 %id)
CB266199 adipose .d 1088 to 1504 1 to 417       417/419
(99 %)
1 diff
(99.8 %id)
FN169331 breast carcinoma .d 1309 to 1416 1 to 113       113/114
(99 %)
6 diff
(94.8 %id)
BE085903 breast .d 1328 to 1613 290 to 8     Submitted on the opposite strand 283/291
(97 %)
0 diff
(100 %id)
BI007395 kidney_tumor .d 1348 to 1773 431 to 8       424/431
(98 %)
0 diff
(100 %id)
AI628134 Kidney .d 1434 to 1889 456 to 1       456/457
(99 %)
4 diff
(99.2 %id)
BE350948 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 1452 to 1922 473 to 1   tiling clone,   473/473
(100 %)
2 diff
(99.6 %id)
AI436116 Kidney .d 1468 to 1889 446 to 23   AAA Submitted on the opposite strand 424/424
(100 %)
9 diff
(97.9 %id)
DB354754 whole embryo, mainly head .d 1524 to 2105 581 to 1       581/586
(99 %)
15 diff
(97.5 %id)
AI921711 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1591 to 2106 517 to 1       517/517
(100 %)
2 diff
(99.7 %id)
AA837462 germinal center B cell .d 1619 to 1896 282 to 6   tiling clone,   277/282
(98 %)
0 diff
(100 %id)
AI684104 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1634 to 2105 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
AI671645 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1639 to 2111 474 to 1       474/474
(100 %)
1 diff
(99.8 %id)
BF475566 sciatic nerve .d 1640 to 2099 461 to 2       460/461
(99 %)
2 diff
(99.6 %id)
AI633110 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1667 to 2085 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AA282100 germinal center B cell .d 1671 to 2092 422 to 1       422/422
(100 %)
0 diff
(100 %id)
AI628220 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1677 to 2107 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
AI625630 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1690 to 2108 423 to 5       419/423
(99 %)
0 diff
(100 %id)
AW197013 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 1708 to 2118 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AI274622 Kidney, renal cell tumor .d 1717 to 1935 378 to 159       220/378
(58 %)
3 diff
(99.3 %id)
FN140750 breast carcinoma .d 1729 to 1817 94 to 1     Submitted on the opposite strand 94/98
(95 %)
6 diff
(93.9 %id)
BM509595 Pancreas, Purified pancreatic islet .d 1747 to 2347 1 to 601       601/601
(100 %)
4 diff
(99.4 %id)
CN388399 embryonic stem cells, cell lines H1, H7, andH9 .d 1759 to 2445 7 to 700       701/700
(100 %)
9 diff
(98.8 %id)
AL548204 placenta, Placenta Cot 25-normalized .d 1781 to 2783 1 to 1002   tiling clone,   1002/1047
(95 %)
7 diff
(99.4 %id)
CN388397 embryonic stem cells, cell lines H1, H7, andH9 .d 1788 to 2302 1 to 515       515/515
(100 %)
0 diff
(100 %id)
CK822542 Pancreas, Purified pancreatic islet .d 1793 to 2373 1 to 581     Submitted on the opposite strand 581/581
(100 %)
5 diff
(99.2 %id)
CR988757 T-Lymphocytes .d 1800 to 2693 1 to 892       892/898
(99 %)
14 diff
(98.5 %id)
CN388398 embryonic stem cells, cell lines H1, H7, andH9 .d 1827 to 2450 15 to 656       616/656
(93 %)
12 diff
(98.2 %id)
BU159078 eye, retinoblastoma .d 1872 to 2789 1 to 919   tiling clone,   919/919
(100 %)
15 diff
(98.4 %id)
AW880139 ovary .d 1882 to 2307 430 to 6       425/444
(95 %)
0 diff
(100 %id)
BE502751 carcinoid, lung .d 1889 to 2389 1 to 501     Submitted on the opposite strand 501/501
(100 %)
1 diff
(99.9 %id)
AA935381 Kidney, kidney tumor .d 1891 to 2114 223 to 1       223/223
(100 %)
0 diff
(100 %id)
BE468024 carcinoid, lung .d 1899 to 2400 29 to 530     Submitted on the opposite strand 502/530
(94 %)
8 diff
(98.5 %id)
BP253242 Kidney .d 1903 to 2484 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AA196729 muscle, skeletal muscle .d 1904 to 2078 175 to 1       175/175
(100 %)
0 diff
(100 %id)
AI611817 brain, tumor, 5 pooled (see description) .d 1907 to 2108 202 to 1       202/202
(100 %)
0 diff
(100 %id)
FN139315 breast carcinoma .d 1918 to 2013 1 to 96       96/96
(100 %)
0 diff
(100 %id)
DR155797 human embryonic stem cells differentiated toan early endodermal cell type .d 2734 to 3482 1 to 749   tiling clone,   749/749
(100 %)
0 diff
(100 %id)
AK027658   .e 1 to 2421 2 to 2422 E327G tiling clone, available from FLJ,   2422/2422
(100 %)
3 diff
(99.9 %id)
DA736289   .e 1 to 823 2 to 824   capped   823/876
(93 %)
7 diff
(99.3 %id)
DA829629 placenta .e 6 to 851 2 to 856   capped   855/861
(99 %)
17 diff
(98.1 %id)
AK291155   .e 194 to 1811 1 to 1618 exact tiling clone,   1618/1618
(100 %)
1 diff
(100.0 %id)
BI092320 cervix .e 601 to 1376 1 to 788       788/1233
(63 %)
40 diff
(96.8 %id)
DA042781 bladder .e 1207 to 1775 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA140388 alzheimer cortex .e 1228 to 1796 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA157259 amygdala .e 1267 to 1830 2 to 570   capped   569/569
(100 %)
7 diff
(98.8 %id)
DA382030 thalamus .e 1267 to 1823 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA040274 bladder .e 1269 to 1833 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AL712666 human skeletal muscle .e 1363 to 1892 1 to 531       531/531
(100 %)
3 diff
(99.5 %id)
DA675690   .e 1479 to 2043 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
FN112405 breast carcinoma .e 1519 to 1620 1 to 97       97/97
(100 %)
7 diff
(92.8 %id)
BE768869 prostate_tumor .e 1780 to 2142 1 to 364       364/364
(100 %)
16 diff
(95.7 %id)
CV364272 prostate_tumor .e 1785 to 2105 321 to 1   tiling clone, Submitted on the opposite strand 321/321
(100 %)
6 diff
(98.2 %id)
DB368739   .e 1877 to 2421 543 to 1       543/572
(94 %)
15 diff
(97.4 %id)
BU078190 Pancreas, Purified pancreatic islet .e 2524 to 3093 1 to 570   tiling clone,   570/570
(100 %)
0 diff
(100 %id)
DB374526 placenta .e 2526 to 2955 430 to 1       430/432
(99 %)
2 diff
(99.6 %id)
AW163298 brain, frontal lobe .e 2656 to 3146 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BF792442 adrenal cortex carcinoma, cell line, adrenal gland .e 2665 to 3486 1 to 820       820/1130
(72 %)
15 diff
(98.7 %id)
CN388401 embryonic stem cells, cell lines H1, H7, andH9 .e 2786 to 3489 13 to 717       705/717
(98 %)
6 diff
(99.2 %id)
TI_149271751   .e 2794 to 3456 159 to 810     Submitted on the opposite strand 652/1060
(61 %)
16 diff
(98.5 %id)
BU674611 lung, Primary Lung Epithelial Cells .e 2804 to 3456 96 to 738     Submitted on the opposite strand 643/685
(93 %)
17 diff
(97.6 %id)
W37125 parathyroid gland, parathyroid tumor .e 2903 to 3338 1 to 442   fully sequenced,   442/442
(100 %)
8 diff
(98.2 %id)
AA284389 germinal center B cell .e 2908 to 3338 1 to 431   fully sequenced,   431/431
(100 %)
0 diff
(100 %id)
BF808458 colon_ins .e 2928 to 3349 12 to 433       422/433
(97 %)
6 diff
(98.7 %id)
C15266   .e 2929 to 3369 1 to 437       437/443
(98 %)
4 diff
(99.1 %id)
BQ000404 Fibrosarcoma .e 2953 to 3683 749 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 731/731
(100 %)
0 diff
(100 %id)
CB160256 Liver .e 2962 to 3537 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
TI_149280443   .e 2977 to 3683 790 to 85   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 706/716
(98 %)
2 diff
(99.8 %id)
BU679222 lung, Primary Lung Epithelial Cells .e 2992 to 3683 709 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 691/691
(100 %)
2 diff
(99.8 %id)
BQ009848 Chondrosarcoma, Left Pubic Bone .e 2994 to 3683 709 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 691/691
(100 %)
1 diff
(99.9 %id)
CX166989 human embryonic stem cells differentiated toan early endodermal cell type .e 2998 to 3647 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
BU690097 Human Lung Epithelial cells, lung .e 3006 to 3683 694 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 676/676
(100 %)
2 diff
(99.8 %id)
CA313075 Human Lung Epithelial cells, lung .e 3015 to 3683 687 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 669/669
(100 %)
5 diff
(99.3 %id)
AA258501 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 3023 to 3434 1 to 412       412/412
(100 %)
0 diff
(100 %id)
CA423407 cell lines, Chondrosarcoma .e 3031 to 3683 672 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
AA461235   .e 3049 to 3534 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
BM717204 eye, lens .e 3049 to 3209 1 to 161   fully sequenced, Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 161/161
(100 %)
0 diff
(100 %id)
BQ024739 placenta .e 3057 to 3683 645 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 627/627
(100 %)
2 diff
(99.7 %id)
BE856835 pooled .e 3058 to 3686 635 to 7       629/638
(98 %)
6 diff
(99.1 %id)
BU077945 Pancreas, Purified pancreatic islet .e 3100 to 3686 590 to 4       587/590
(99 %)
0 diff
(100 %id)
AW291173   .e 3102 to 3674 590 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 573/573
(100 %)
1 diff
(99.9 %id)
AA772155 parathyroid gland, parathyroid tumor .e 3165 to 3675 514 to 6       509/514
(99 %)
1 diff
(99.9 %id)
TI_149275309   .e 3169 to 3683 641 to 125   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 517/534
(96 %)
26 diff
(95.2 %id)
AI436781 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 3175 to 3686 511 to 1       511/511
(100 %)
1 diff
(99.9 %id)
BM669247 eye, lens .e 3179 to 3674 514 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 496/496
(100 %)
0 diff
(100 %id)
AI452408 pooled .e 3204 to 3686 487 to 5       483/487
(99 %)
0 diff
(100 %id)
AI400686 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 3206 to 3682 476 to 1       476/476
(100 %)
5 diff
(99.0 %id)
AA922667 pooled germ cell tumors .e 3228 to 3683 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
BI459243 testis .e 3250 to 4014 1 to 773   available from MGC,   773/777
(99 %)
30 diff
(96.2 %id)
BC033061 testis .e 3254 to 4987 5 to 1738   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1734/1734
(100 %)
3 diff
(99.9 %id)
W33162 parathyroid gland, parathyroid tumor .e 3308 to 3675 381 to 6   fully sequenced,   376/381
(98 %)
5 diff
(98.7 %id)
AA292718 germinal center B cell .e 3328 to 3683 356 to 1   fully sequenced,   356/356
(100 %)
0 diff
(100 %id)
AA460931   .e 4293 to 4709 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AW157501 brain, frontal lobe .e 4466 to 4992 531 to 5       527/531
(99 %)
0 diff
(100 %id)
AJ420559   .f 1 to 1572 10 to 1579   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1570/1587
(98 %)
5 diff
(99.7 %id)
DA028966   .f 212 to 776 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
AI684188 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 468 to 971 505 to 1       505/505
(100 %)
1 diff
(99.9 %id)
AI679194 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 526 to 971 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
AI633057 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 563 to 975 413 to 1       413/418
(98 %)
0 diff
(100 %id)
BU742538 eye, fetal eye .f 2815 to 3535 737 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 721/723
(99 %)
0 diff
(100 %id)
TI_149288678   .f 2844 to 3535 779 to 89   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 691/694
(99 %)
2 diff
(99.8 %id)
AW968444   .f 2849 to 3534 686 to 1     Submitted on the opposite strand 686/691
(99 %)
3 diff
(99.6 %id)
AA809998 germinal center B cell .f 2859 to 3253 405 to 11   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 395/395
(100 %)
0 diff
(100 %id)
BM970503 lung .f 2862 to 3535 689 to 17   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 673/673
(100 %)
2 diff
(99.8 %id)
AA885519 pooled .f 2999 to 3535 557 to 21   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 537/537
(100 %)
0 diff
(100 %id)
DB295744   .f 3014 to 3541 530 to 1       530/530
(100 %)
2 diff
(99.7 %id)
AW150035 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 3022 to 3535 514 to 1       514/514
(100 %)
0 diff
(100 %id)
AA458855 germinal center B cell .f 3119 to 3535 417 to 1       417/417
(100 %)
0 diff
(100 %id)
FN052256 breast carcinoma .f 3124 to 3222 1 to 99       99/99
(100 %)
0 diff
(100 %id)
AA765561 germinal center B cell .f 3128 to 3535 418 to 11   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 408/408
(100 %)
0 diff
(100 %id)
AA426051   .f 3229 to 3534 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AA714915 Ewing's sarcoma .f 3261 to 3521 261 to 1       261/261
(100 %)
0 diff
(100 %id)
AF351615   .g 1 to 1258 9 to 1267 K134E S272G P287L T289P N321D ...     1267/1267
(100 %)
13 diff
(99.0 %id)
CB128192 Liver .g 1 to 500 7 to 506       506/506
(100 %)
2 diff
(99.7 %id)
DB464070 hippocampus .g 1 to 456 5 to 460       460/460
(100 %)
3 diff
(99.4 %id)
BU659816 blood .g 1 to 431 14 to 443       433/443
(97 %)
7 diff
(98.5 %id)
BF247047 brain, glioblastoma .g 1 to 582 4 to 588       588/589
(99 %)
36 diff
(93.9 %id)
BF245904 brain, glioblastoma .g 1 to 650 4 to 652       652/655
(99 %)
12 diff
(98.2 %id)
NM_017421.3   .g 1 to 1262 4 to 1265 exact RefSeq,   1265/1265
(100 %)
0 diff
(100 %id)
BF240504 bone marrow, from acute myelogenous leukemia .g 1 to 631 3 to 624       624/845
(73 %)
19 diff
(97.8 %id)
DA899573 skeletal muscle .g 1 to 560 4 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
AK056955 skeletal muscle .g 1 to 1334 2 to 1336 S272G Y329H tiling clone, available from FLJ,   1336/1336
(100 %)
4 diff
(99.8 %id)
AL136726 Kidney .g 1 to 1258 2 to 1259 G21V N180D Y329H available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1259/1260
(99 %)
5 diff
(99.7 %id)
DA131619 alzheimer cortex .g 1 to 636 3 to 638   capped   637/637
(100 %)
0 diff
(100 %id)
BF692803 muscle (skeletal) .g 1 to 688 2 to 679       679/891
(76 %)
46 diff
(94.9 %id)
BM791496 stomach .g 1 to 639 2 to 640       640/640
(100 %)
1 diff
(99.9 %id)
DA511668 brain .g 1 to 536 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA893011 skeletal muscle .g 1 to 534 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
TI_44343604   .g 3 to 617 85 to 700       616/700
(88 %)
8 diff
(98.9 %id)
BI667645 brain, hypothalamus .g 4 to 617 1 to 614       614/614
(100 %)
7 diff
(98.9 %id)
BM785516 stomach .g 5 to 633 18 to 648       631/631
(100 %)
5 diff
(99.3 %id)
CD698787 normal nasopharynx .g 6 to 456 33 to 483       451/483
(93 %)
6 diff
(98.8 %id)
BU568086 testis .g 6 to 759 1 to 753       753/774
(97 %)
14 diff
(98.2 %id)
BU929029 brain, glioblastoma .g 6 to 855 1 to 850       850/883
(96 %)
20 diff
(97.8 %id)
BF956322 nervous_normal .g 9 to 188 187 to 13       175/188
(93 %)
1 diff
(99.5 %id)
DB501364 hypothalamus .g 9 to 482 1 to 465       465/465
(100 %)
10 diff
(97.9 %id)
BG563457 Liver .g 10 to 857 1 to 843       843/847
(99 %)
23 diff
(97.3 %id)
BF696779 brain, primitive neuroectoderm .g 11 to 708 1 to 689       689/870
(79 %)
39 diff
(95.6 %id)
BG574909 breast, mammary adenocarcinoma, cell line .g 11 to 647 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
DN993371 brain, whole brain .g 11 to 598 1 to 588       588/588
(100 %)
5 diff
(99.2 %id)
BU162712 large cell carcinoma, lung .g 14 to 753 12 to 752       741/865
(85 %)
13 diff
(98.5 %id)
BM825462 Ascites, stomach .g 14 to 597 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BP338598 Spleen .g 15 to 589 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BF212562 bone marrow, from chronic myelogenous leukemia .g 17 to 736 1 to 711       711/877
(81 %)
25 diff
(97.2 %id)
BF246206 brain, glioblastoma .g 18 to 738 1 to 731       731/733
(99 %)
55 diff
(92.5 %id)
BF216739 brain, glioblastoma .g 18 to 732 1 to 708       708/792
(89 %)
26 diff
(96.8 %id)
BF211496 bone marrow, from chronic myelogenous leukemia .g 19 to 661 1 to 638       638/699
(91 %)
8 diff
(98.9 %id)
TI_1948215500   .g 19 to 541 124 to 646   fully sequenced,   523/646
(80 %)
6 diff
(99.1 %id)
TI_1948215664   .g 19 to 541 120 to 641   fully sequenced,   522/641
(81 %)
8 diff
(98.8 %id)
TI_1948215831   .g 19 to 476 124 to 581   fully sequenced,   458/581
(78 %)
6 diff
(99.0 %id)
TI_1948215981   .g 19 to 500 122 to 603   fully sequenced,   482/603
(79 %)
7 diff
(98.9 %id)
BX404140 neuroblastoma .g 20 to 784 1 to 765   fully sequenced,   765/765
(100 %)
9 diff
(98.9 %id)
CR607786 neuroblastoma .g 20 to 1238 1 to 1219 exact tiling clone,   1219/1219
(100 %)
0 diff
(100 %id)
Z24884 leg muscle, skeletal muscle .g 21 to 356 1 to 336       336/336
(100 %)
1 diff
(99.8 %id)
CF122890 CNCAP(3)T-225 cell line, Prostate .g 21 to 635 8 to 622       615/622
(98 %)
0 diff
(100 %id)
TI_154182611   .g 21 to 851 46 to 873       828/829
(99 %)
16 diff
(98.1 %id)
BC063463 Brain, adult, 6 pooled whole brains .g 22 to 1261 1 to 1241 S272G Y329H tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1241/1241
(100 %)
4 diff
(99.7 %id)
BI752416 brain .g 22 to 842 1 to 810       810/812
(99 %)
21 diff
(97.5 %id)
BU178869 leiomyosarcoma, uterus .g 22 to 759 1 to 748       748/901
(83 %)
22 diff
(97.6 %id)
BU173473 leiomyosarcoma, uterus .g 22 to 872 1 to 858       858/913
(93 %)
15 diff
(98.4 %id)
TI_57218168   .g 22 to 842 27 to 836       810/838
(96 %)
25 diff
(97.1 %id)
EL734959 mixed .g 25 to 701 1 to 675       675/677
(99 %)
3 diff
(99.6 %id)
BC001534 Lymph, Burkitt lymphoma .g 27 to 1261 1 to 1235   available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1235/1235
(100 %)
1 diff
(100.0 %id)
BE271219 Burkitt lymphoma, lymph .g 27 to 848 26 to 836   available from MGC,   811/975
(83 %)
27 diff
(97.3 %id)
BE268425 Burkitt lymphoma, lymph .g 27 to 751 12 to 730       719/739
(97 %)
22 diff
(97.1 %id)
CX788696 human embryonic stem cells .g 28 to 826 1 to 798       798/798
(100 %)
1 diff
(99.9 %id)
CR598978 Neuroblastoma Cot 25-normalized .g 29 to 1233 1 to 1205       1205/1205
(100 %)
0 diff
(100 %id)
AL526037.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 29 to 784 1 to 757   fully sequenced, also hits gene GPBP1L1 757/757
(100 %)
7 diff
(99.1 %id)
BE268576 Burkitt lymphoma, lymph .g 29 to 695 30 to 687       658/780
(84 %)
17 diff
(97.9 %id)
CB146018 Liver .g 35 to 598 1 to 565       565/565
(100 %)
3 diff
(99.5 %id)
BC015634 Skin, melanotic melanoma. .g 37 to 1260 1 to 1225   available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1225/1225
(100 %)
4 diff
(99.7 %id)
BE397921 Burkitt lymphoma, lymph .g 45 to 682 1 to 639       639/739
(86 %)
23 diff
(96.9 %id)
BM928266 brain .g 47 to 922 1 to 886       886/1153
(76 %)
42 diff
(96.4 %id)
BF106444 lung .g 48 to 641 1 to 595       595/595
(100 %)
6 diff
(99.0 %id)
AF193016   .g 54 to 1236 1 to 1177   AAA   1177/1271
(92 %)
15 diff
(98.9 %id)
BF025951 melanotic melanoma, skin .g 56 to 818 1 to 758   available from MGC,   758/964
(78 %)
11 diff
(98.9 %id)
BE294903 muscle, rhabdomyosarcoma .g 62 to 695 1 to 640       640/641
(99 %)
9 diff
(98.6 %id)
CB112783 Liver .g 67 to 639 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
BI196021 brain, neuroblastoma .g 88 to 848 1 to 767       767/767
(100 %)
19 diff
(97.6 %id)
BE535635 cervix .g 92 to 821 1 to 722       722/727
(99 %)
18 diff
(97.6 %id)
FN060965 breast carcinoma .g 135 to 244 1 to 110       110/110
(100 %)
0 diff
(100 %id)
BX448485 fetal liver, Liver .g 325 to 1246 928 to 4       925/928
(99 %)
20 diff
(97.9 %id)
CV028930 mixed .g 382 to 1036 1 to 651       651/657
(99 %)
10 diff
(98.5 %id)
TI_1948085117   .g 383 to 1041 128 to 797       670/1227
(54 %)
21 diff
(98.3 %id)
BE271027 Burkitt lymphoma, lymph .g 408 to 1212 807 to 1   available from MGC,   807/901
(89 %)
18 diff
(98.1 %id)
TI_1948085297   .g 409 to 913 154 to 659       509/1335
(38 %)
29 diff
(97.9 %id)
TI_149287713   .g 409 to 1261 882 to 38   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 845/974
(86 %)
17 diff
(98.3 %id)
TI_149299833   .g 411 to 1261 956 to 111   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 846/952
(88 %)
22 diff
(97.7 %id)
TI_1948215832   .g 446 to 1138 811 to 118   fully sequenced,   694/811
(85 %)
7 diff
(99.2 %id)
TI_1948215982   .g 470 to 1138 789 to 116   fully sequenced,   674/789
(85 %)
11 diff
(98.7 %id)
TI_1948215501   .g 480 to 1130 776 to 125   fully sequenced,   652/776
(84 %)
1 diff
(99.9 %id)
TI_1948215665   .g 480 to 1130 774 to 123   fully sequenced,   652/774
(84 %)
1 diff
(99.9 %id)
BG182453   .g 508 to 1251 749 to 10     Submitted on the opposite strand 740/866
(85 %)
33 diff
(96.2 %id)
BQ305099 breast .g 522 to 1037 568 to 52       517/568
(91 %)
6 diff
(99.0 %id)
TI_149294682   .g 522 to 1330 887 to 80   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 808/976
(82 %)
10 diff
(99.0 %id)
BU683323 lung .g 553 to 1330 794 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 779/779
(100 %)
3 diff
(99.7 %id)
CD247688 embryonic stem cells, WA01, passage 38 .g 610 to 1267 22 to 682       661/697
(94 %)
19 diff
(97.3 %id)
TI_149272041   .g 626 to 1332 789 to 84   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 706/960
(73 %)
5 diff
(99.5 %id)
BU674806 lung, Primary Lung Epithelial Cells .g 654 to 1332 694 to 17   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 678/678
(100 %)
5 diff
(99.3 %id)
BF001472 colon, colon tumor, RER+ .g 685 to 1036 352 to 1       352/352
(100 %)
10 diff
(97.2 %id)
BU621915 Cell Line, Chondrosarcoma .g 701 to 1260 578 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 560/563
(99 %)
15 diff
(97.4 %id)
BX411847 neuroblastoma .g 723 to 1238 514 to 1   fully sequenced,   514/514
(100 %)
6 diff
(98.9 %id)
AL525985.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 723 to 1233 512 to 1   fully sequenced, also hits gene GPBP1L1 512/512
(100 %)
7 diff
(98.7 %id)
BG185051   .g 751 to 1331 1 to 583       583/586
(99 %)
12 diff
(98.0 %id)
BG191333   .g 751 to 1262 1 to 512       512/514
(99 %)
11 diff
(97.9 %id)
BG196929   .g 751 to 1333 1 to 583       583/592
(98 %)
13 diff
(97.9 %id)
BG217324   .g 752 to 1333 1 to 583       583/587
(99 %)
10 diff
(98.3 %id)
BG194782   .g 754 to 1251 513 to 10     Submitted on the opposite strand 504/921
(54 %)
11 diff
(98.9 %id)
BG216833   .g 754 to 1331 5 to 583       579/586
(98 %)
12 diff
(98.0 %id)
BG184539   .g 757 to 1331 7 to 583       577/586
(98 %)
11 diff
(98.2 %id)
BG201047   .g 757 to 1333 7 to 582       576/676
(85 %)
11 diff
(98.4 %id)
AI376968   .g 758 to 1267 506 to 2       505/511
(98 %)
8 diff
(98.5 %id)
BG197945   .g 759 to 1268 10 to 520       511/772
(66 %)
12 diff
(98.5 %id)
BG190370   .g 760 to 1265 12 to 518       507/518
(97 %)
12 diff
(97.7 %id)
BG218877   .g 760 to 1333 13 to 586       574/589
(97 %)
9 diff
(98.5 %id)
BG182390   .g 767 to 934 1 to 167       167/167
(100 %)
7 diff
(95.9 %id)
BG210959   .g 767 to 1330 1 to 565   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 565/565
(100 %)
14 diff
(97.6 %id)
BF476112 Kidney .g 772 to 1332 562 to 1       562/562
(100 %)
3 diff
(99.5 %id)
AI828921 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .g 775 to 1332 559 to 1       559/559
(100 %)
6 diff
(99.0 %id)
AI682238 pooled .g 778 to 1329 553 to 1       553/553
(100 %)
27 diff
(95.2 %id)
BG202592   .g 791 to 1041 1 to 252       252/254
(99 %)
6 diff
(97.7 %id)
DB330874 skeletal muscle .g 796 to 1334 540 to 1       540/540
(100 %)
4 diff
(99.3 %id)
BG204527   .g 797 to 1289 1 to 494       494/893
(55 %)
21 diff
(97.7 %id)
BG211459   .g 797 to 1080 1 to 284       284/287
(98 %)
9 diff
(96.9 %id)
AI767763 2 pooled tumors (clear cell type), Kidney .g 799 to 1329 534 to 3       532/534
(99 %)
4 diff
(99.3 %id)
AA128069 uterus .g 816 to 1267 1 to 457       457/458
(99 %)
11 diff
(97.6 %id)
AA777297 liver and spleen .g 818 to 1327 513 to 1       513/514
(99 %)
15 diff
(97.1 %id)
BX451366 neuroblastoma .g 835 to 1267 1 to 432       432/433
(99 %)
8 diff
(98.2 %id)
BG195878   .g 842 to 1260 7 to 426       420/430
(97 %)
15 diff
(96.6 %id)
AI700896 Kidney .g 851 to 1331 493 to 7       487/493
(98 %)
6 diff
(98.8 %id)
AA708598 uterus .g 854 to 1261 426 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 409/409
(100 %)
2 diff
(99.6 %id)
DB572558 hypothalamus .g 857 to 1330 1 to 475     Submitted on the opposite strand 475/475
(100 %)
3 diff
(99.4 %id)
AA551442 normal prostatic epithelial cells, Prostate .g 862 to 1260 424 to 25   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 400/400
(100 %)
3 diff
(99.3 %id)
AI919254   .g 871 to 1333 469 to 7       463/469
(98 %)
3 diff
(99.4 %id)
AI961017 pooled germ cell tumors .g 910 to 1259 352 to 3       350/356
(98 %)
0 diff
(100 %id)
BG235889 blood, lymphocyte .g 1023 to 1260 241 to 3       239/241
(99 %)
0 diff
(100 %id)
F00446 leg muscle, skeletal muscle .g 1049 to 1241 194 to 1       194/194
(100 %)
1 diff
(99.5 %id)
BG198494   .g 1075 to 1319 261 to 16     Submitted on the opposite strand 246/261
(94 %)
0 diff
(100 %id)
BI549221 brain, hippocampus .h 1 to 580 1 to 582   tiling clone,   582/582
(100 %)
9 diff
(98.5 %id)
TI_44167349   .h 1 to 580 54 to 635       582/635
(91 %)
11 diff
(98.3 %id)
CD686406 normal nasopharynx .h 12 to 687 18 to 693       676/693
(97 %)
10 diff
(98.6 %id)
CB985528 Pooled-Glandular .h 14 to 530 1 to 521   tiling clone,   521/785
(66 %)
19 diff
(97.6 %id)
CB120800 cervix, Uterine .h 20 to 567 1 to 549       549/549
(100 %)
4 diff
(99.3 %id)
BE544118 cervical carcinoma cell line, cervix .h 30 to 696 1 to 666       666/684
(97 %)
14 diff
(98.0 %id)
BQ923555 leiomyosarcoma, uterus .h 32 to 874 1 to 842   tiling clone,   842/1054
(79 %)
11 diff
(99.0 %id)
BF725958 eye, Iris .h 64 to 405 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
CA311870 Human Lung Epithelial cells, lung .h 677 to 1309 652 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 634/639
(99 %)
4 diff
(99.4 %id)
CD701765 normal nasopharynx .i 1 to 654 34 to 687   tiling clone,   660/687
(96 %)
7 diff
(99.0 %id)
BF963130 nervous_normal .i 264 to 829 566 to 2       565/567
(99 %)
0 diff
(100 %id)
DA811256 brain .i 576 to 1146 2 to 572   tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
BF528229 anaplastic oligodendroglioma with 1p/19qloss, brain .i 596 to 984 1 to 394       394/394
(100 %)
16 diff
(96.0 %id)
AI936531 pooled .i 601 to 1195 595 to 1       595/595
(100 %)
3 diff
(99.5 %id)
AI375937   .i 736 to 1191 456 to 1       456/457
(99 %)
1 diff
(99.8 %id)
AI375954   .i 743 to 1191 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
AI220613 pooled .i 792 to 1192 401 to 1       401/401
(100 %)
0 diff
(100 %id)
AI886507 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i 802 to 1192 391 to 1       391/391
(100 %)
1 diff
(99.8 %id)
AA807340 germinal center B cell .i 813 to 1198 389 to 4   tiling clone,   386/391
(98 %)
0 diff
(100 %id)
AA731274 germinal center B cell .i 817 to 1198 385 to 4       382/385
(99 %)
0 diff
(100 %id)
BP338376 Spleen .i 885 to 1464 1 to 580   tiling clone,   580/580
(100 %)
1 diff
(99.9 %id)
FN172658 breast carcinoma .i 899 to 994 95 to 1     Submitted on the opposite strand 95/95
(100 %)
3 diff
(96.9 %id)
AW081113 colon, moderately differentiated adenocarcinoma .i 1306 to 1843 556 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 539/539
(100 %)
1 diff
(99.9 %id)
AI620373 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 1464 to 1846 384 to 2   tiling clone,   383/384
(99 %)
1 diff
(99.8 %id)
CD692351 normal nasopharynx .j 1 to 611 39 to 649   tiling clone,   611/649
(94 %)
8 diff
(98.8 %id)
BP216149 corpus callosum .j 48 to 633 1 to 588       588/588
(100 %)
6 diff
(99.0 %id)
TI_149291845   .j 393 to 1069 752 to 81   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 672/697
(96 %)
13 diff
(98.2 %id)
AI625821 Kidney .j 433 to 1069 638 to 1   tiling clone,   638/647
(98 %)
9 diff
(98.7 %id)
BU682235 lung .j 450 to 1069 631 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 616/616
(100 %)
9 diff
(98.6 %id)
BI459995 testis .k 1 to 742 4 to 784       736/786
(93 %)
62 diff
(92.2 %id)
BI459919 testis .k 1 to 654 4 to 657   tiling clone, available from MGC,   657/661
(99 %)
6 diff
(99.1 %id)
BC042850 testis .k 3 to 1145 1 to 1143 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1143/1143
(100 %)
0 diff
(100 %id)
DB097010 testis .l 1 to 572 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
DB504943 hypothalamus .l 14 to 500 1 to 487       487/487
(100 %)
1 diff
(99.8 %id)
DB576204 hypothalamus .l 455 to 947 1 to 493   tiling clone, Submitted on the opposite strand 493/493
(100 %)
0 diff
(100 %id)
CB147548 Liver .m 1 to 559 11 to 569 R47M K57E tiling clone,   569/569
(100 %)
3 diff
(99.5 %id)
DA223877 brain .n 1 to 608 2 to 613   tiling clone, capped   612/612
(100 %)
4 diff
(99.4 %id)
DA857096 placenta .n 1 to 549 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB101234 thymus .n 8 to 462 2 to 456   capped   455/455
(100 %)
0 diff
(100 %id)
DA193533 amygdala .n 25 to 597 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
CV412315 colon .n 409 to 675 9 to 279   tiling clone,   271/291
(93 %)
10 diff
(96.6 %id)
BG033338 breast, mammary adenocarcinoma, cell line .o 1 to 709 1 to 701 L139F S140P Y141M A142P L143G ... tiling clone,   701/881
(79 %)
13 diff
(98.6 %id)
DB143458 thymus .p 1 to 538 2 to 539 exact tiling clone, capped   538/538
(100 %)
0 diff
(100 %id)
DB071070 testis .q 1 to 538 2 to 540 W9L Q10A Q11A W12V P13A ... tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
TI_57179094   .q 4 to 729 29 to 784 W2C D3G Q4I G5K G6A ...     753/888
(84 %)
55 diff
(93.9 %id)
BI771260 pooled lung and spleen .q 5 to 776 1 to 805 W2C D3G Q4I G5K G6A ...     802/859
(93 %)
52 diff
(94.0 %id)
BQ271224 Pancreas, Purified pancreatic islet .q 47 to 605 1 to 559 Q44L R45C E46* tiling clone, fully sequenced,   559/559
(100 %)
4 diff
(99.3 %id)
DB551403 hippocampus .q 417 to 1144 1 to 718     Submitted on the opposite strand 718/719
(99 %)
15 diff
(98.0 %id)
BF083885 colon .q 445 to 835 403 to 12       392/403
(97 %)
0 diff
(100 %id)
DB544498 hippocampus .q 464 to 1144 1 to 680     Submitted on the opposite strand 680/681
(99 %)
7 diff
(99.0 %id)
DB636719 testis .q 500 to 1144 1 to 645   tiling clone, Submitted on the opposite strand 645/646
(99 %)
3 diff
(99.6 %id)
H01763 placenta .q 570 to 944 1 to 382   fully sequenced,   382/382
(100 %)
8 diff
(98.0 %id)
BX110847 placenta .q 571 to 1140 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
R80046 placenta .q 571 to 929 1 to 362   fully sequenced,   362/362
(100 %)
3 diff
(99.2 %id)
R81893 placenta .q 571 to 990 1 to 422   fully sequenced,   422/422
(100 %)
8 diff
(98.2 %id)
H01138 placenta .q 571 to 917 1 to 354   fully sequenced,   354/354
(100 %)
2 diff
(99.5 %id)
BQ270927 Pancreas, Purified pancreatic islet .q 577 to 1143 567 to 1   fully sequenced,   567/567
(100 %)
4 diff
(99.3 %id)
N66397 cochlea, ear .q 580 to 1143 563 to 1       563/636
(88 %)
15 diff
(97.7 %id)
AI862562 2 pooled tumors (clear cell type), Kidney .q 616 to 1145 529 to 1   tiling clone,   529/529
(100 %)
1 diff
(99.9 %id)
H01139 placenta .q 887 to 1146 265 to 1   fully sequenced,   265/265
(100 %)
2 diff
(99.3 %id)
R79953 placenta .q 899 to 1135 237 to 1   fully sequenced,   237/237
(100 %)
1 diff
(99.6 %id)
H01017 placenta .q 914 to 1147 236 to 1   fully sequenced,   236/236
(100 %)
6 diff
(97.5 %id)
R81791 placenta .q 960 to 1141 187 to 1   fully sequenced,   187/187
(100 %)
1 diff
(99.5 %id)
BU854266 testis .r 1 to 675 5 to 679   tiling clone,   679/774
(87 %)
8 diff
(99.0 %id)
DB002756 breast, tumor tissue .r 21 to 571 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
CN266597 embryonic stem cells, cell lines H1, H7, andH9 .r 33 to 763 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
DA440935 tongue, tumor tissue .r 34 to 578 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
AJ420570   .r 35 to 2869 6 to 2840 exact tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 2835/2840
(99 %)
7 diff
(99.8 %id)
DB462075 testis .r 40 to 695 1 to 655       655/655
(100 %)
3 diff
(99.6 %id)
AA328681   .r 123 to 460 1 to 341       341/341
(100 %)
3 diff
(99.2 %id)
DA935509 Spleen .r 555 to 1152 2 to 598   capped   597/597
(100 %)
2 diff
(99.7 %id)
CA397842 eye, RPE/choroid .r 691 to 1264 1 to 574       574/574
(100 %)
5 diff
(99.2 %id)
DA128080 cerebellum .r 1099 to 1670 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
AU184948 skin .r 1114 to 1432 1 to 319       319/319
(100 %)
2 diff
(99.4 %id)
DA832260 placenta .r 1157 to 1767 2 to 613   capped   612/618
(99 %)
5 diff
(99.2 %id)
N92007 liver and spleen .r 1495 to 1647 1 to 153       153/153
(100 %)
0 diff
(100 %id)
CR742847 liver and spleen .r 1498 to 2220 1 to 723 exact tiling clone,   723/723
(100 %)
0 diff
(100 %id)
Z30287   .r 1570 to 1792 11 to 233       223/233
(95 %)
6 diff
(97.5 %id)
AW960846   .r 1916 to 2395 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
DA508859 brain .r 1919 to 2467 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA509375 brain .r 1919 to 2491 2 to 575   capped   574/576
(99 %)
2 diff
(99.7 %id)
AA321647 lymphoid .r 1945 to 2187 1 to 243       243/243
(100 %)
0 diff
(100 %id)
BQ270146 Pancreas, Purified pancreatic islet .r 2010 to 2523 3 to 516   fully sequenced,   514/516
(99 %)
5 diff
(99.1 %id)
CA947181 Pancreas, Purified pancreatic islet .r 2010 to 2477 4 to 471   fully sequenced,   468/471
(99 %)
5 diff
(99.0 %id)
DB332809 Spleen .r 2311 to 2869 559 to 1       559/559
(100 %)
0 diff
(100 %id)
DB300934 cerebellum .r 2351 to 2900 556 to 4       553/562
(98 %)
0 diff
(100 %id)
DB378356 placenta .r 2375 to 2869 492 to 1       492/492
(100 %)
4 diff
(99.2 %id)
CA946888 Pancreas, Purified pancreatic islet .r 2447 to 2868 422 to 1   fully sequenced,   422/422
(100 %)
0 diff
(100 %id)
N63862 liver and spleen .r 2457 to 2871 415 to 1       415/416
(99 %)
0 diff
(100 %id)
BQ286810 Pancreas, Purified pancreatic islet .r 2493 to 2868 377 to 1   fully sequenced,   377/377
(100 %)
1 diff
(99.8 %id)
BP251583 hippocampus .s 1 to 581 2 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
DA159071 amygdala .s 11 to 596 2 to 587 exact capped   586/586
(100 %)
1 diff
(99.9 %id)
W56079 parathyroid gland, parathyroid tumor .s 14 to 511 1 to 507 W9X Q10S Q11S W12G L14*     505/507
(99 %)
18 diff
(96.5 %id)
TI_57192657   .s 43 to 872 56 to 888 exact     833/837
(99 %)
27 diff
(96.8 %id)
BI862481 breast, mammary adenocarcinoma, cell line .s 44 to 872 1 to 832 exact tiling clone,   832/836
(99 %)
27 diff
(96.8 %id)
TI_57165934   .s 45 to 797 29 to 785 exact     701/796
(88 %)
31 diff
(96.2 %id)
BI835770 pooled pancreas and spleen .s 48 to 797 1 to 754 exact tiling clone,   698/765
(91 %)
25 diff
(96.8 %id)
CA438182 lung, Lung Focal Fibrosis .t 1 to 576 19 to 594 exact tiling clone, Submitted on the opposite strand 576/576
(100 %)
0 diff
(100 %id)
CN256063 embryonic stem cells, cell lines H1, H7, andH9 .t 10 to 528 12 to 530       519/530
(97 %)
6 diff
(98.9 %id)
BX648520 human retina .u 1 to 2110 1 to 2116   tiling clone, available from DKFZ, AAA   2116/2116
(100 %)
5 diff
(99.8 %id)
DA395366 thalamus .u 77 to 622 2 to 547   capped   546/550
(99 %)
1 diff
(99.9 %id)
H65522 liver and spleen .u 105 to 579 1 to 483   fully sequenced,   483/483
(100 %)
21 diff
(95.7 %id)
BQ014174 Chondrosarcoma, Left Pubic Bone .u 133 to 890 757 to 1       757/757
(100 %)
1 diff
(99.9 %id)
BF094533 uterus_tumor .u 140 to 664 1 to 524       524/524
(100 %)
21 diff
(96.0 %id)
BF094761 uterus_tumor .u 141 to 678 16 to 553       538/565
(95 %)
14 diff
(97.6 %id)
BF094734 uterus_tumor .u 157 to 679 524 to 3       522/525
(99 %)
14 diff
(97.4 %id)
BF094543 uterus_tumor .u 171 to 677 1 to 506       506/506
(100 %)
8 diff
(98.5 %id)
BF094611 uterus_tumor .u 178 to 669 508 to 17       492/516
(95 %)
10 diff
(98.1 %id)
CD368206 Alveolar Macrophage, lung .u 189 to 890 698 to 1       698/731
(95 %)
8 diff
(99.0 %id)
BE934203 head_neck .u 190 to 454 25 to 288       264/289
(91 %)
8 diff
(97.3 %id)
BF092532 testis_normal .u 190 to 679 10 to 495       486/501
(97 %)
23 diff
(95.5 %id)
BE934208 head_neck .u 199 to 531 11 to 343       333/343
(97 %)
6 diff
(98.3 %id)
BG142211 Islets of Langerhans, Pancreas .u 341 to 848 1 to 503       503/514
(97 %)
12 diff
(97.7 %id)
BF094849 uterus_tumor .u 345 to 671 329 to 1       329/329
(100 %)
11 diff
(96.7 %id)
R79763 placenta .u 361 to 677 1 to 334   fully sequenced,   334/334
(100 %)
9 diff
(97.4 %id)
BF896229 marrow .u 365 to 586 21 to 243       223/255
(87 %)
16 diff
(93.8 %id)
BM272668 insulinoma, Pancreas .u 366 to 829 464 to 1       464/464
(100 %)
1 diff
(99.8 %id)
BG142131 Islets of Langerhans, Pancreas .u 369 to 856 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
BP397388 pancreatic islet .u 375 to 875 1 to 502     Submitted on the opposite strand 502/502
(100 %)
1 diff
(99.9 %id)
AW601934 breast .u 376 to 883 22 to 530       509/530
(96 %)
6 diff
(98.9 %id)
FN158154 breast carcinoma .u 380 to 476 97 to 1     Submitted on the opposite strand 97/97
(100 %)
0 diff
(100 %id)
AI457423 carcinoid, lung .u 396 to 874 479 to 1       479/479
(100 %)
8 diff
(98.4 %id)
AI379439 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .u 398 to 875 478 to 1       478/478
(100 %)
0 diff
(100 %id)
BF888355 testis_normal .u 401 to 577 183 to 6     Submitted on the opposite strand 178/185
(96 %)
0 diff
(100 %id)
AA732812 heart .u 408 to 874 466 to 1       466/466
(100 %)
2 diff
(99.6 %id)
AA772545 parathyroid gland, parathyroid tumor .u 421 to 880 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AI022851 parathyroid gland, parathyroid tumor .u 428 to 880 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AA699484 liver and spleen .u 432 to 887 455 to 1       455/455
(100 %)
5 diff
(99.0 %id)
BQ778477 Pancreas, Purified pancreatic islet .u 437 to 881 446 to 1       446/446
(100 %)
3 diff
(99.4 %id)
AI056525 liver and spleen .u 439 to 874 437 to 1       437/437
(100 %)
2 diff
(99.6 %id)
BM312327 Pancreas, Purified pancreatic islet .u 451 to 875 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
AI016207   .u 451 to 878 428 to 1       428/428
(100 %)
0 diff
(100 %id)
AA648783 germinal center B cell .u 452 to 799 348 to 1       348/348
(100 %)
1 diff
(99.8 %id)
AA857271 pharynx, squamous cell carcinoma .u 462 to 845 384 to 1       384/384
(100 %)
1 diff
(99.8 %id)
AW297252   .u 463 to 889 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AA708849 uterus .u 472 to 874 403 to 1       403/403
(100 %)
2 diff
(99.6 %id)
AI033881 parathyroid gland, parathyroid tumor .u 473 to 880 408 to 1       408/408
(100 %)
1 diff
(99.8 %id)
AI799253 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .u 488 to 874 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
AI056097 parathyroid gland, parathyroid tumor .u 494 to 880 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI250345 lymph node, lymphoma, follicular mixed small and largecell .u 528 to 874 348 to 1       348/348
(100 %)
1 diff
(99.8 %id)
H65324 liver and spleen .u 552 to 868 321 to 1   fully sequenced,   321/321
(100 %)
9 diff
(97.2 %id)
AA771720 parathyroid gland, parathyroid tumor .u 553 to 880 328 to 1       328/328
(100 %)
6 diff
(98.2 %id)
AA890065 parathyroid gland, parathyroid tumor .u 566 to 833 268 to 1       268/268
(100 %)
3 diff
(98.9 %id)
AI209018 placenta .u 568 to 833 266 to 1       266/266
(100 %)
0 diff
(100 %id)
AI917439 pooled germ cell tumors .u 577 to 874 298 to 1       298/298
(100 %)
0 diff
(100 %id)
H87733.
matches multiple genes
eye, retina .u 618 to 862 245 to 1     Submitted on the opposite strand, also hits gene C6orf108 245/252
(97 %)
0 diff
(100 %id)
AA811930 germinal center B cell .u 633 to 835 203 to 1       203/203
(100 %)
4 diff
(98.1 %id)
AW450697   .u 634 to 874 1 to 240   AAA Submitted on the opposite strand 240/240
(100 %)
2 diff
(99.2 %id)
R79764 placenta .u 647 to 878 234 to 2   fully sequenced,   233/234
(99 %)
2 diff
(99.2 %id)
TI_154126147   .u 651 to 1450 877 to 78   AAA   800/939
(85 %)
23 diff
(97.6 %id)
BU616874 Cell Line, Chondrosarcoma .u 652 to 1402 771 to 17   AAA   755/755
(100 %)
4 diff
(99.5 %id)
AI333795 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .u 737 to 875 139 to 1       139/139
(100 %)
1 diff
(99.3 %id)
BQ430463 embryonal carcinoma, cell line, testis .u 741 to 1584 1 to 858   tiling clone,   858/877
(97 %)
18 diff
(98.0 %id)
AA910588 leiomyosarcoma, soft tissue .u 796 to 877 82 to 1       82/82
(100 %)
0 diff
(100 %id)
CA416365 Chondrosarcoma Cell line .u 801 to 1450 668 to 13   AAA   656/659
(99 %)
4 diff
(99.4 %id)
T06787   .u 944 to 1306 1 to 367       367/367
(100 %)
3 diff
(99.2 %id)
AA988137 carcinoid, lung .u 1006 to 1449 448 to 5       444/448
(99 %)
0 diff
(100 %id)
AW117445 pooled .u 1017 to 1401 388 to 3       386/506
(76 %)
0 diff
(100 %id)
DA374149 thalamus .u 1085 to 1692 2 to 610   capped   609/609
(100 %)
1 diff
(99.9 %id)
W29122 eye, retina .u 1102 to 1812 18 to 729       712/897
(79 %)
6 diff
(99.4 %id)
AI768553 Kidney .u 1112 to 1419 309 to 1       309/309
(100 %)
1 diff
(99.7 %id)
AI912739 carcinoid, lung .u 1115 to 1449 335 to 1       335/335
(100 %)
0 diff
(100 %id)
BE272415 adenocarcinoma cell line, ovary .u 1116 to 1744 12 to 639       628/642
(97 %)
5 diff
(99.3 %id)
BF591606 carcinoid, lung .u 1116 to 1449 338 to 5       334/338
(98 %)
0 diff
(100 %id)
AI700806 Kidney .u 1143 to 1446 305 to 1       305/305
(100 %)
1 diff
(99.7 %id)
CV570793 cornea, eye .u 1207 to 1567 1 to 361       361/361
(100 %)
6 diff
(98.4 %id)
BE766959 nervous_tumor .u 1229 to 1551 1 to 321       321/322
(99 %)
5 diff
(98.5 %id)
BE177267 head_neck .u 1441 to 1825 389 to 11     Submitted on the opposite strand 379/389
(97 %)
0 diff
(100 %id)
AW023100 cochlea, ear .u 1519 to 1923 8 to 412       405/412
(98 %)
6 diff
(98.6 %id)
BP280426   .u 1540 to 2137 1 to 598       598/598
(100 %)
0 diff
(100 %id)
CB046820 2 pooled tumors (clear cell type), Kidney .u 1542 to 1798 16 to 272   fully sequenced,   257/272
(94 %)
5 diff
(98.2 %id)
BQ186071 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u 1559 to 2044 1 to 486       486/486
(100 %)
1 diff
(99.8 %id)
AA534850 colon .u 1654 to 2119 472 to 7       466/472
(98 %)
0 diff
(100 %id)
AK027751 placenta .u 1692 to 3631 1 to 1939   tiling clone, available from FLJ,   1939/1939
(100 %)
3 diff
(99.9 %id)
DA828035 placenta .u 1693 to 2306 2 to 617   capped   616/620
(99 %)
6 diff
(99.1 %id)
AA332173 Embryo, 8 weeks .u 1695 to 1998 1 to 304       304/304
(100 %)
0 diff
(100 %id)
AW965315   .u 1703 to 2271 1 to 568       568/581
(97 %)
6 diff
(99.0 %id)
BU675213 lung, Primary Lung Epithelial Cells .u 1729 to 2336 626 to 19   tiling clone, AAA   608/608
(100 %)
0 diff
(100 %id)
AA805172 germinal center B cell .u 1732 to 2057 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AI936503 pooled .u 1747 to 2189 458 to 17       442/458
(96 %)
0 diff
(100 %id)
CB046819 2 pooled tumors (clear cell type), Kidney .u 1768 to 2111 387 to 44   fully sequenced, AAA   344/344
(100 %)
3 diff
(99.2 %id)
AI216496 pooled .u 1792 to 2172 381 to 1       381/381
(100 %)
0 diff
(100 %id)
AW300101 Kidney .u 1792 to 2325 534 to 1       534/534
(100 %)
3 diff
(99.5 %id)
AI928497 Kidney .u 1811 to 2325 526 to 12   AAA   515/515
(100 %)
3 diff
(99.5 %id)
BQ012602 placenta .u 1814 to 2325 530 to 19   AAA   512/512
(100 %)
0 diff
(100 %id)
AI816817 2 pooled tumors (clear cell type), Kidney .u 1824 to 2325 510 to 9       502/510
(98 %)
0 diff
(100 %id)
AA808503 germinal center B cell .u 1831 to 2178 351 to 4       348/351
(99 %)
0 diff
(100 %id)
BQ012117 placenta .u 1881 to 2325 464 to 20   AAA   445/445
(100 %)
1 diff
(99.8 %id)
AI766903 2 pooled tumors (clear cell type), Kidney .u 1918 to 2266 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AW194639 Kidney .u 1959 to 2196 238 to 1       238/238
(100 %)
10 diff
(95.8 %id)
DA948286 Spleen .u 2281 to 2854 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB108627 thymus .u 2604 to 3186 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
BX090393 liver and spleen .u 2735 to 3449 57 to 771       715/771
(92 %)
6 diff
(99.3 %id)
CA865751 Pancreas, Purified pancreatic islet .u 2899 to 3231 28 to 361       334/361
(92 %)
6 diff
(98.4 %id)
CA951056 Pancreas, Purified pancreatic islet .u 2920 to 3423 10 to 513       504/513
(98 %)
6 diff
(98.9 %id)
BM717700 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u 2978 to 3338 1 to 361   AAA   361/361
(100 %)
0 diff
(100 %id)
AI377922 pooled .u 3009 to 3339 339 to 5       335/339
(98 %)
0 diff
(100 %id)
N80365 liver and spleen .u 3038 to 3238 1 to 201       201/204
(98 %)
1 diff
(99.6 %id)
AI809758 pooled .u 3116 to 3631 516 to 1       516/516
(100 %)
3 diff
(99.5 %id)
AI540119 B-cell, chronic lymphotic leukemia .u 3140 to 3631 492 to 1       492/492
(100 %)
0 diff
(100 %id)
AI692741 carcinoid, lung .u 3142 to 3582 441 to 1       441/441
(100 %)
0 diff
(100 %id)
T86289 liver and spleen .u 3156 to 3631 493 to 1       493/493
(100 %)
20 diff
(96.0 %id)
AA677622 liver and spleen .u 3168 to 3631 464 to 1       464/464
(100 %)
0 diff
(100 %id)
AW082958 pooled .u 3234 to 3631 398 to 1       398/398
(100 %)
0 diff
(100 %id)
BC024655 Brain, anaplastic oligodendroglioma with1p/19q loss .u 3234 to 3631 1 to 398   available from MGC, AAA   398/398
(100 %)
1 diff
(99.8 %id)
BF345423 anaplastic oligodendroglioma with 1p/19qloss, brain .u 3234 to 3631 1 to 396   available from MGC, AAA   396/396
(100 %)
3 diff
(99.3 %id)
AA740838 germinal center B cell .u 3242 to 3637 399 to 4       396/399
(99 %)
1 diff
(99.8 %id)
CN343733 embryonic stem cells, DMSO-treated H9 cellline .u 3334 to 3847 1 to 514 exact tiling clone,   514/514
(100 %)
0 diff
(100 %id)
DB475684 hippocampus .va 1 to 687 1 to 685 T69X N85X F86L N87H     685/686
(99 %)
8 diff
(98.9 %id)
DB482539 hippocampus .va 1 to 735 1 to 733 Q91X tiling clone,   733/733
(100 %)
10 diff
(98.7 %id)
CB989028 Human Placenta, placenta .va 1 to 647 28 to 678 exact     651/792
(82 %)
17 diff
(97.9 %id)
BG433155 Kidney .va 27 to 826 1 to 814 L94X L95W     814/815
(99 %)
19 diff
(97.7 %id)
BM875572 insulinoma, Pancreas .va 33 to 600 1 to 568 exact tiling clone,   568/568
(100 %)
4 diff
(99.3 %id)
BU567497 testis .va 38 to 875 1 to 838 exact tiling clone,   838/839
(99 %)
12 diff
(98.6 %id)
BM875325 insulinoma, Pancreas .va 617 to 1184 568 to 1   tiling clone,   568/568
(100 %)
0 diff
(100 %id)
CN343725 embryonic stem cells, DMSO-treated H9 cellline .vb 1 to 583 1 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
TI_149272628   .vb 344 to 1047 788 to 86   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 703/992
(70 %)
3 diff
(99.7 %id)
AA463323   .vc 1 to 448 1 to 447   tiling clone,   447/447
(100 %)
2 diff
(99.6 %id)
BP380675   .vc 5 to 706 1 to 703 G93X     703/742
(94 %)
14 diff
(98.2 %id)
DA082438 cerebellum .vc 7 to 577 2 to 572 exact capped   571/571
(100 %)
1 diff
(99.9 %id)
BC107700 Pooled, 40 cell lines .vc 11 to 988 1 to 978 P13L tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 978/978
(100 %)
5 diff
(99.5 %id)
BU598920 mixed (pool of 40 RNAs) .vc 12 to 783 1 to 777 P13L     777/777
(100 %)
24 diff
(97.0 %id)
BE568991 bladder, carcinoma, cell line .vc 15 to 704 1 to 685 W34G A35L A36H L37G A38P ...     685/861
(79 %)
34 diff
(96.1 %id)
BP229913 brain .vc 17 to 600 1 to 582 exact     582/582
(100 %)
4 diff
(99.4 %id)
BP225598   .vc 20 to 603 1 to 582 exact     582/582
(100 %)
3 diff
(99.5 %id)
BP217470 caudate nucleus .vc 21 to 604 1 to 583 exact     583/583
(100 %)
5 diff
(99.2 %id)
BF569722 Kidney, renal carcinoma (ascites) .vc 23 to 401 1 to 379   fully sequenced,   379/379
(100 %)
1 diff
(99.8 %id)
DA366686 subthalamic nucleus .vc 24 to 586 2 to 564 exact capped   563/563
(100 %)
0 diff
(100 %id)
BP234545 coronary artery .vc 32 to 618 1 to 587 exact     587/587
(100 %)
0 diff
(100 %id)
BM928359 brain .vc 37 to 1027 22 to 1027 exact tiling clone,   1006/1095
(91 %)
56 diff
(94.9 %id)
BP430995   .vc 45 to 499 1 to 454 N87T R88E M89C W90G Q91N ...     454/454
(100 %)
4 diff
(99.2 %id)
BG283051 adenocarcinoma, cell line, Prostate .vc 53 to 699 1 to 655 P57A     655/1129
(58 %)
17 diff
(98.5 %id)
BF570452 Kidney, renal carcinoma (ascites) .vc 371 to 948 583 to 2   fully sequenced,   582/583
(99 %)
2 diff
(99.7 %id)
AA463215   .vc 618 to 988 371 to 1       371/371
(100 %)
3 diff
(99.2 %id)
BG700991 brain, hippocampus .vd 1 to 700 7 to 706 exact     706/712
(99 %)
10 diff
(98.6 %id)
BP365266 lung .vd 1 to 581 2 to 581 exact     581/581
(100 %)
2 diff
(99.7 %id)
DB127225 thymus .vd 1 to 558 2 to 559 Q39* tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
BM556556 duodenal adenocarcinoma, cell line, small intestine .vd 7 to 868 1 to 865 exact tiling clone,   865/999
(86 %)
19 diff
(98.1 %id)
DA115156 cerebellum .vd 21 to 582 2 to 563 exact capped   562/562
(100 %)
0 diff
(100 %id)
BM312630 Pancreas, Purified pancreatic islet .vd 37 to 621 1 to 585 exact     585/585
(100 %)
0 diff
(100 %id)
CA335180 posterior tongue (pooled) .vd 41 to 660 1 to 620 exact     620/620
(100 %)
1 diff
(99.9 %id)
AV763289 bone marrow .ve 1 to 575 2 to 571 Q31R L95X F96V tiling clone,   571/572
(99 %)
19 diff
(96.7 %id)
DB194593 trachea .vf-u 1 to 555 8 to 562 Y26H tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
BX089903   .vg 1 to 505 1 to 505 exact tiling clone,   505/505
(100 %)
3 diff
(99.5 %id)
AA626029   .vh 1 to 395 397 to 3 exact tiling clone,   395/397
(99 %)
0 diff
(100 %id)
BM667175 eye, fetal eyes Gene SFRS18andCOQ3, variant not shown       AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base)    
BM698006 eye, fetal eyes Gene SFRS18andCOQ3, variant not shown         Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base)    
CD237405 Pituitary Gene SFRS18andCOQ3, variant not shown              
AA223246 brain, neuroepithelial cells Gene SFRS18andCOQ3, variant not shown              
AA223462 brain, neuroepithelial cells Gene SFRS18andCOQ3, variant not shown              
374 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf-u, .vg, .vh Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI